Purbanchal cancer hospital in Nepal has introduced PET/CT Positron emission tomography/computed tomography is a rapidly growing modality that has made a tremendous impact on the care of patients with cancer.
PET scans use a small amount of a radioactive substance, or tracer, to show differences between healthy tissue and diseased tissue.
The most commonly used tracer is 18F-FDG (Fluoro-deoxy-glucose).
The combination of PET/CT provides complete information about both structure (CT) and function (PET) in the human body.
Application of PET:
Oncological Application (>95%):
Lymphoma, Head and Neck Cancers, Lung cancer, Breast cancers, RCC, Gynaecological malignancies, Metastasis, Carcinoma of Unknown Primary etc.
Useful for:
Diagnosis of Malignancy
Staging of various cancers
Response Evaluation after Chemotherapy, Radiotherapy, Surgery or Immunotherapy
